This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 2012-2015.
Company Filing History:
Years Active: 2012-2015
Title: Jochen Schact: Innovator in Hearing Loss Treatment
Introduction
Jochen Schact is a prominent inventor based in Ann Arbor, MI (US), known for his significant contributions to the field of hearing loss treatment. With a total of 2 patents, Schact has developed innovative compositions aimed at improving auditory health.
Latest Patents
Schact's latest patents focus on compositions for treating hearing loss. The first patent discloses a composition that consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. This composition may optionally include a withanolide and/or resveratrol. The combination of these components provides an additive effect that is equal to or greater than the sum of the effects of the individual components. The second patent outlines a method of treating hearing loss that includes a composition with components functioning through different biological mechanisms. This composition includes a biologically effective amount of at least one scavenger of singlet oxygen, a donor antioxidant, a third antioxidant, and a vasodilator. The method emphasizes the importance of administering this composition within three days of trauma to a mammal's middle or inner ear.
Career Highlights
Jochen Schact is affiliated with the University of Michigan, where he continues to advance research in auditory health. His work has garnered attention for its potential to significantly impact the treatment of hearing loss.
Collaborations
Some of Schact's notable coworkers include Josef M Miller and Colleen G LePrell, who contribute to the collaborative efforts in research and development within the field.
Conclusion
Jochen Schact's innovative work in developing compositions for treating hearing loss showcases his dedication to improving auditory health. His contributions are paving the way for new treatment options in this critical area of healthcare.
